Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 4
Submit an article Journal homepage
1,030
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Study on the pro-inflammatory mechanism of the HuD antibody in promoting M1 polarization and paraneoplastic neurological syndrome occurrence

Liang YinDepartment of Neurology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Bengbu Anhui, ChinaView further author information
,
Wen-Ling YuanDepartment of Neurology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Bengbu Anhui, ChinaView further author information
,
Ke WuDepartment of Neurology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Bengbu Anhui, ChinaView further author information
,
Li-Na ZhangDepartment of Neurology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Bengbu Anhui, ChinaView further author information
&
Qian-Qian LiDepartment of Neurology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Bengbu Anhui, ChinaCorrespondenceEmail:[email protected] [email protected]
View further author information
Pages 8029-8037 | Received 07 Jan 2022, Accepted 04 Mar 2022, Published online: 16 Mar 2022

References

  • Zhang L, Qian W, Chen Q, et al. Imbalance in circulating T lymphocyte subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes. Cell Immunol. 2014;290(2):245–250.
  • Laguna B, Hayward JH, Lee AY, et al. Paraneoplastic neurologic syndrome as a presentation of underlying breast malignancy. Breast J. 2018;24(6):1038–1042.
  • Abid G, Khan B, Rafiq Z, et al. Child Trade-Off Theory: a Theoretical Discussion on the Structure, Causes, Consequences, and Eradication of Child Labor. Bulletin of Business and Economics. 2015;4(1):24–34.
  • Zekeridou A, Lennon VA. Neurologic autoimmunity in the era of checkpoint inhibitor cancer immunotherapy. Paper presented at the Mayo Clinic proceedings. Mayo Clin Proc. 2019;94(9):1865–1878.
  • Kazarian M, Laird-Offringa IA. Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer. 2011;10(1):1–19.
  • Mikołaj Piotr Z, Patrycja S, Krystyna O, et al. Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy. Cancer Immunol Immunother. 2021;70(5):1277–1289.
  • Tanaka K, Kawamura M, Sakimura K, et al. Significance of Autoantibodies in Autoimmune Encephalitis in Relation to Antigen Localization: an Outline of Frequently Reported Autoantibodies with a Non-Systematic Review. Int J Mol Sci. 2020;21(14):4941.
  • Matsumoto T, Ryuge S, Kobayashi M, et al. Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung. Int J Oncol. 2012;40(6):1957–1962.
  • Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Paper presented at the Mayo Clinic Proceedings. Mayo Clin Proc. 2010 Sep;85(9):838–854.
  • Remark R, Becker C, Gomez JE, et al. The non–small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome. Am J Respir Crit Care Med. 2015;191(4):377–390.
  • Piotr Zaborowski M, Michalak S. Cell-mediated immune responses in paraneoplastic neurological syndromes. Clin Dev Immunol. 2013;2013:630602.
  • Yang CY, Lin CK, Lin GJ, et al. Triptolide represses oral cancer cell proliferation, invasion, migration, and angiogenesis in co-inoculation with U937 cells. Clin Oral Investig. 2017 Jan;21(1):419–427.
  • Madhavan AA, Carr CM, Morris PP, et al. Imaging Review of Paraneoplastic Neurologic Syndromes. AJNR Am J Neuroradiol. 2020;41(12):2176–2187.
  • Pignolet BS, Gebauer CM, Liblau RS. Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: a beneficial antitumor immune response going awry. Oncoimmunology. 2013;2(12):e27384.
  • Rossi S, Merli E, Rinaldi R, et al. Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review. J Neurol. 2021;21:10577–10578.
  • Perrone-Bizzozero N, Bird CW. Role of HuD in nervous system function and pathology. Front Biosci (Schol Ed). 2013;5(2):554–563.
  • Jung M, Lee EK. RNA-Binding Protein HuD as a Versatile Factor in Neuronal and Non-Neuronal Systems. Biology (Basel). 2021;10(5):361.
  • Storstein A, Monstad SE, Nakkestad HL, et al. Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay. J Neurol. 2004;251(2):197–203.
  • Maat P, Brouwer E, Hulsenboom E, et al. Multiplex serology of paraneoplastic antineuronal antibodies. J Immunol Methods. 2013;391(1–2):125–132.
  • Antoine JC, Camdessanché JP. Paraneoplastic disorders of the peripheral nervous system. Presse Med. 2013;42(6):e235–44.
  • Hu D, Nicholls PK, Claus M, et al. Immunofluorescence characterization of innervation and nerve-immune cell interactions in mouse lymph nodes. Eur J Histochem. 2019 Oct 18;63(4):3059.
  • Waisman A, Hauptmann J, Regen T. The role of IL-17 in CNS diseases. Acta Neuropathol. 2015;129(5):625–637.
  • Yshii LM, Hohlfeld R, Liblau RS. Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives. Nat Rev Neurol. 2017;13(12):755–763.
  • de Graaf M, de Beukelaar J, Bergsma J, et al. B and T cell imbalances in CSF of patients with Hu-antibody associated PNS. J Neuroimmunol. 2008 Mar;195(1–2):164–170.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.